This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
09/01/15 - 10:30:35 AM ET (BATS BZX Real-time Price)
Div Yield: --
BIOC Day's Range
BIOC 52 Week Range
BIOC Business Summary
Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA tests utilizing a standard blood sample.View BIOC key stats
Biocept Inc - BIOC - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Biocept Inc as a
Sell with a ratings score of D.
Report Snippet: We rate BIOCEPT INC (BIOC) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and generally disappointing historical performance in the stock itself.